Canadian Biomaterials Society
La Société Canadienne des Biomatériaux

Dear CBS Members, The World Biomaterials Congress 2024 WBC2024 is soliciting recommendations for plenary speakers...

Through the BioInnovation Institute Science Prize for Innovation, the editors of Science seek to recognize bold researchers who are asking fundamental questions at the intersection of the life sciences and entrepreneurship...

We are pleased to open the call for applications for the CBS Mentorship and Professional Development, a program specifically designed to connect professionals outside of academia with graduate students and postdoctoral fellows coming from the Canadian biomaterial s community...

14th Intl Symposium on Biodegradable Metals for Applications on behalf of Professor Mantovani and the Quebec City Student Chapter Want to discover the next generation of bioresorbable metals aiming to bridge the gap between biomaterials and tissue engineering for pediatric, dental, orthopedic, vascular, cardiac, neurological applications, and more? The final program of the upcoming 14th Intl Symposium on Biodegradable Metals for Biomedical Applications is now online...

Biofouling due to irreversible accumulation of micro and macro-organism has become a serious threat to medical, marine, and other manufacturing industries...

Developing safe and efficient strategies to deliver CRISPR-Cas9 clustered regularly interspaced palindromic repeats-CRISPR associated protein 9 complexes into cells has grown in importance over recent years, with an increasing demand for non-viral methods to enable clinical translation...

Infection comprises more than 75 of the mortality in burn wound injuries. Increased scarring and delay in wound healing process are the other detrimental impacts of infection on the burn wounds, necessitating the early detection of the infection at the wound site in clinical practices...

Hemophilia is a bleeding disorder that affects roughly 1 in 5000 live births. A form of this disease, hemophilia B, is caused by deficiencies of the clotting protein, factor IX FIX , which is part of the coagulation cascade that, when activated by vascular injury, generates fibrin and its crosslinker, factor XIIIa FXIIIa ...

Hemophilia is a bleeding disorder that affects roughly 1 in 5000 live births. A form of this disease, hemophilia B, is caused by deficiencies of the clotting protein, factor IX FIX , which is part of the coagulation cascade that, when activated by vascular injury, generates fibrin and its crosslinker, factor XIIIa FXIIIa ...